Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H8INO3 |
Molecular Weight | 309.0708 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CNC(=O)C1=CC=CC=C1[131I]
InChI
InChIKey=CORFWQGVBFFZHF-AKGSDVBQSA-N
InChI=1S/C9H8INO3/c10-7-4-2-1-3-6(7)9(14)11-5-8(12)13/h1-4H,5H2,(H,11,14)(H,12,13)/i10+4
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/23424193Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/20150248 | https://www.ncbi.nlm.nih.gov/pubmed/12766604 | https://www.ncbi.nlm.nih.gov/pubmed/10321824
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23424193
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/20150248 | https://www.ncbi.nlm.nih.gov/pubmed/12766604 | https://www.ncbi.nlm.nih.gov/pubmed/10321824
IODOHIPPURIC ACID I-131 (ortho-Iodohippuric Acid I-131, [I-123]-OIH) is an iodine-containing compound used in pyelography as a radiopaque medium. Iodine-123 labelled ortho-Iodohippuric acid was used in the early 1970's as a kidney imaging agent or tracer that "lights-up" inside your body when scanned, but over the years its use has declined. [I-123]-OIH is primarily extracted by the renal tubules and has excellent pharmacokinetic properties, with a clearance only slightly less than that of p-aminohippuran, but its use has been compromised by the suboptimal imaging characteristics of the 364-keV photon of 131I and the delivery of relatively high radiation doses to kidneys and thyroid in patients with impaired renal function
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23424193
After the coinjection of approximately 74 MBq (;2 mCi) of 99mTc(CO)3(NTA) and approximately 11.1 MBq (300 mCi) of 131I-OIH, imaging was performed for 24 min using an Infinia camera (GE Healthcare) with a 9.5-mm (3/8-in) crystal fitted with a high-energy collimator
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2124
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
||
|
NDF-RT |
N0000000205
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
||
|
WHO-ATC |
V09CX02
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
||
|
NDF-RT |
N0000177914
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
16O34995MB
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
71800
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
1203-90-3
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
C80645
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY | |||
|
DTXSID10923312
Created by
admin on Fri Dec 15 16:27:27 GMT 2023 , Edited by admin on Fri Dec 15 16:27:27 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)